Mecanismo de accin El mecanismo de Retatrutida se basa en la activacin simultnea y balanceada de tres receptores acoplados a protenas G de clase B: GLP-1R, GIP-R y GCG-R
To put that into perspective, someone who started the trial at 300 pounds could theoretically lose about 60 pounds on tirzepatide versus roughly 41 pounds on semaglutide over about a year and four months
The entire process happens virtually: Complete an online medical intake form Consultation with a licensed provider (typically within 24-48 hours) If approved, medication ships directly to your home Monthly follow-ups via telehealth platform This model eliminates the need for in-person doctor visits while maintaining appropriate medical oversight throughout your treatment
Stopping too early The most common mistake
Phase 2 trial (NEJM, 2023) The landmark Phase 2 trial, published in the New England Journal of Medicine, randomized 338 adults with obesity to receive weekly subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks
5A,B,D), INS-1 and MIN6 cells (Fig
